Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
Panettieri RA Jr, Welte T, Shenoy KV, et al. J Asthma Allergy. 2020;13:115–126.The authors have advised that the symbol shown on page 124, discussion section, left column, line 5 “≥20%” should read “<20%”.Read the orig...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-onset-of-effect-changes-in-airflow-obstruction-and-lung-vo-peer-reviewed-article-JAA |
id |
doaj-3098aa8b71d8474ab1b4dd312f139d67 |
---|---|
record_format |
Article |
spelling |
doaj-3098aa8b71d8474ab1b4dd312f139d672020-11-25T02:25:11ZengDove Medical PressJournal of Asthma and Allergy1178-69652020-03-01Volume 1313513652500Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]Panettieri RA JrWelte TShenoy KVKorn SJandl MKerwin EMFeijoo RBarker POlsson RFMartin UJPanettieri RA Jr, Welte T, Shenoy KV, et al. J Asthma Allergy. 2020;13:115–126.The authors have advised that the symbol shown on page 124, discussion section, left column, line 5 “≥20%” should read “<20%”.Read the original articlehttps://www.dovepress.com/corrigendum-onset-of-effect-changes-in-airflow-obstruction-and-lung-vo-peer-reviewed-article-JAAanti–il-5rαbenralizumabinterleukin-5randomized controlled trialeosinophilicsevere asthma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Panettieri RA Jr Welte T Shenoy KV Korn S Jandl M Kerwin EM Feijoo R Barker P Olsson RF Martin UJ |
spellingShingle |
Panettieri RA Jr Welte T Shenoy KV Korn S Jandl M Kerwin EM Feijoo R Barker P Olsson RF Martin UJ Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum] Journal of Asthma and Allergy anti–il-5rα benralizumab interleukin-5 randomized controlled trial eosinophilic severe asthma |
author_facet |
Panettieri RA Jr Welte T Shenoy KV Korn S Jandl M Kerwin EM Feijoo R Barker P Olsson RF Martin UJ |
author_sort |
Panettieri RA Jr |
title |
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum] |
title_short |
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum] |
title_full |
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum] |
title_fullStr |
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum] |
title_full_unstemmed |
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum] |
title_sort |
onset of effect, changes in airflow obstruction and lung volume, and health-related quality of life improvements with benralizumab for patients with severe eosinophilic asthma: phase iiib randomized, controlled trial (solana) [corrigendum] |
publisher |
Dove Medical Press |
series |
Journal of Asthma and Allergy |
issn |
1178-6965 |
publishDate |
2020-03-01 |
description |
Panettieri RA Jr, Welte T, Shenoy KV, et al. J Asthma Allergy. 2020;13:115–126.The authors have advised that the symbol shown on page 124, discussion section, left column, line 5 “≥20%” should read “<20%”.Read the original article |
topic |
anti–il-5rα benralizumab interleukin-5 randomized controlled trial eosinophilic severe asthma |
url |
https://www.dovepress.com/corrigendum-onset-of-effect-changes-in-airflow-obstruction-and-lung-vo-peer-reviewed-article-JAA |
work_keys_str_mv |
AT panettierirajr onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT weltet onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT shenoykv onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT korns onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT jandlm onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT kerwinem onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT feijoor onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT barkerp onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT olssonrf onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum AT martinuj onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum |
_version_ |
1724852495367274496 |